To assess role of purgation in Vatarakta (Gouty arthritis)

A Comparative Clinical Evaluation Of Virechana Karma With Aragvadhadi Avaleha And Kashmaryadi Kwatha In Vatarakta (Gouty Arthritis)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055848

Enrollment

Registered

2023-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with the clinical features of Vatarakta. 2. Patients with either sex between the age group of 30 to 70 years. 3. Patients fit for Virechana Karma. 4. Patients showing the uric acid level above 6 mg/dl. 5. Patients with chronicity of disease more than 6 month less than 5 years.

Exclusion criteria

Exclusion criteria: 1. Patients unfit for Virechana Karma. 2. Patients with uncontrolled diabetes, HTN, systemic disorders and endocrine disorders and any other malignancy. 3. Patients with autoimmune disease of joints. 4. Patients with infection and communicable disease. 5. Pregnant, lactating mother and menstruating females. 6. Patients associated with rheumatoid arthritis, osteoarthritis.

Design outcomes

Primary

Measure	Time frame
Relief in pain, swelling, redness, tenderness & other symtomsTimepoint: 45 days	—

Secondary

Measure	Time frame
Level of uric acid lower downTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Sonal

HIMALAYIYA AYURVEDIC PG MEDICAL COLLEGE AND HOSPITAL

sonal0459@gmail.com08398008450

Outcome results